Abstract:Background Inflammation and fibrosis play an important role in the pathogenesis of atrial fibrillation ( AF ) after myocardial infarction ( MI ). CTRP9 (C1q/tumor necrosis factor‐related protein‐9) as a secreted glycoprotein can reverse left ventricle remodeling post‐ MI , but its effects on MI ‐induced atrial inflammation, fibrosis, and associated AF are unknown. Methods and Results MI model rats received adenoviral supplementation of CTRP 9 (Ad‐ CTRP 9) by jugular‐vein injection. Cardiac function, inflammatory, and fibrotic indexes and related signaling pathways, electrophysiological properties, and AF inducibility of atria in vivo and ex vivo were detected in 3 or 7 days after MI . shCTRP9 (short hairpin CTRP9) and sh RNA were injected into rat and performed similar detection at day 5 or 10. Adverse atrial inflammation and fibrosis, cardiac dysfunction were induced in both MI and Ad‐GFP (adenovirus‐encoding green fluorescent protein)+ MI rats. Systemic CTRP 9 treatment improved cardiac dysfunction post‐ MI . CTRP 9 markedly ameliorated macrophage infiltration and attenuated the inflammatory responses by downregulating interleukin‐1β and interleukin‐6, and upregulating interleukin‐10, in 3 days post‐ MI ; depressed left atrial fibrosis by decreasing the expressions of collagen types I and III , α‐ SMA , and transforming growth factor β1 in 7 days post‐ MI possibly through depressing the Toll‐like receptor 4/nuclear factor‐κB and Smad2/3 signaling pathways. Electrophysiologic recordings showed that increased AF inducibility and duration, and prolongation of interatrial conduction time induced by MI were attenuated by CTRP 9; moreover, CTRP 9 was negatively correlated with interleukin‐1β and AF duration. Downregulation of CTRP 9 aggravated atrial inflammation, fibrosis, susceptibility of AF and prolonged interatrial conduction time, without affecting cardiac function. Conclusions CTRP 9 is effective at attenuating atrial inflammation and fibrosis, possibly via its inhibitory effects on the Toll‐like receptor 4/nuclear factor‐κB and Smad2/3 signaling pathways, and may be an original upstream therapy for AF in early phase of MI .

CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation

C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation

C1q/tumor Necrosis Factor-Related Protein-3 Acts As a Target Treating Hepatic Fibrosis

Effect Of Ctrp3 On Activation Of Adventitial Fibroblasts Induced By Tgf-Beta 1 From Rat Aorta In Vitro

CTRP15 Derived from Cardiac Myocytes Attenuates TGFβ1-induced Fibrotic Response in Cardiac Fibroblasts.

CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post‐Myocardial Infarction Rats

CTRP3 alleviates mitochondrial dysfunction and oxidative stress injury in pathological cardiac hypertrophy by activating UPRmt via the SIRT1/ATF5 axis

C1q/Tumor Necrosis Factor-Related Protein-3, a Newly Identified Adipokine, is a Novel Antiapoptotic, Proangiogenic, and Cardioprotective Molecule in the Ischemic Mouse Heart

CTRP3 alleviates myocardial ischemia/reperfusion injury in mice through activating LAMP1/JIP2/JNK pathway

Myofibroblast Ccn3 is Regulated by Yap and Wwtr1 and Contributes to Adverse Cardiac Outcomes

C1q/tumor Necrosis Factor-Related Protein-3 Enhances the Contractility of Cardiomyocyte by Increasing Calcium Sensitivity.

20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fibroblasts proliferation and collagen deposition through TGFBR1 signaling pathways

Abstract 8965: C1q/TNF-Related Protein-3, a Newly Identified Adipokine, is a Novel Anti-Apoptotic, Pro-Angiogenic, and Cardioprotective Molecule in the Ischemic Mouse Heart

C1q-tumour Necrosis Factor-Related Protein-3 Exacerbates Cardiac Hypertrophy in Mice.

CTRP3 Attenuates Hepatic Stellate Cell Activation Through Transforming Growth Factor-Β/smad Signaling Pathway.

C1q/Tumor Necrosis Factor-Related Protein-9, A Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling In The Ischemic Mouse Heart Via Protein Kinase A Activation

CTRP3 alleviates cardiac ischemia/reperfusion injury via LAMP1/JIP2/JNK signaling pathway

Abstract P2049: Myofibroblast Depletion of Yap and Wwtr1 Improves Cardiac Function after Myocardial Infarction Via Ccn3 Suppression

Overexpression of CTRP3 Protects Against Sepsis-Induced Myocardial Dysfunction in Mice.

The Mechanism of SIRT3 Regulating SRV2-Mediated Mitochondrial Fission of Fibroblasts to Inhibit Myocardial Fibrosis after Acute Myocardial Infarction

SIRT3 Inhibits Ang II-induced Transdifferentiation of Cardiac Fibroblasts Through Β-Catenin/ppar-γ Signaling